Home » Archive

Xconomy

News, Syndication, Xconomy »

Cubist Adds Antibiotic Punch, Buys Trius and Optimer for $1.24B

Posted by sandiegobiotech July 30th, 2013 .
No Comments

Cubist Pharmaceuticals wants to become more than another biotech company with a nice little franchise built around a single drug. So today it opened up the checkbook, shelled out more than $1.24…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Pharma Fails Credibility Test, Misses Opportunity, on Transparency

Posted by sandiegobiotech July 29th, 2013 .
No Comments

Some of the biggest scandals in the pharmaceutical industry (think Vioxx and Avandia) have been about drug safety, and how much of the clinical trial data on prescription drugs—especially the…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

After Raising $59M, aTyr Plans Physiocrines Proof-of-Concept Trials

Posted by sandiegobiotech July 28th, 2013 .
No Comments

San Diego’s aTyr Pharma says today it has closed on $59 million in a Series D financing to advance its development of a new class of protein-based drugs for treating rare immune diseases. The $59…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Connect CEO Improving From Head Injury After Bike Crash in Mountains

Posted by sandiegobiotech July 25th, 2013 .
No Comments

Connect CEO Duane Roth, who sustained a head injury while bicycling Sunday in the Cuyamaca Mountains east of San Diego, has passed through the most-critical period after undergoing emergency surgery…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Illumina, Conatus, Isis, and More

Posted by sandiegobiotech July 25th, 2013 .
No Comments

San Diego biotech companies are continuing to take advantage of Wall Street’s goodwill toward the life sciences sector, but venture capital funding in the area dropped to a four-year low. Here’s our…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Ex-Prometheus Exec Takes the Reins at Dallas’ Gradalis

Posted by sandiegobiotech July 23rd, 2013 .
No Comments

Gradalis, a Dallas-based life sciences startup, announced today that it has hired pharmaceutical veteran Joseph M. Limber to lead the company as it further develops its personalized vaccine for…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts

Posted by sandiegobiotech July 22nd, 2013 .
No Comments

The year is only half over, but one of the biggest biotech stories of 2013 is going to be the resurgence of the biotech IPO market. It’s a good news/bad news story, depending on where you stand, and…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More

Posted by sandiegobiotech July 18th, 2013 .
No Comments

A number of San Diego life sciences companies appeared to be taking advantage of the strengthening biotech market on Wall Street by raising capital or repositioning themselves—or both. Here’s…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks

Posted by sandiegobiotech July 15th, 2013 .
No Comments

Sometime in the coming weeks, South San Francisco-based Onyx Pharmaceuticals (NASDAQ: ONXX) will probably be acquired by some big drugmaker for more than $10 billion. Shareholders will count their…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

New Carlsbad “Germinator” Opens for Startups as DIY Biology Blooms

Posted by sandiegobiotech July 9th, 2013 .
No Comments

As an activist and founder of the Bay Area’s annual Open Science Summit, Joseph Jackson posed an intriguing question on Xconomy a few years ago: “Can a generation of “DIY” biology hobbyists help…

[[Click headline to continue reading.]]

More...